This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF Rating Add Compare Share Share Ratings Stock AnalysisHoldingsRatingsShort InterestTrendsBuy This Stock Range Cancer Therapeutics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CNCR Aggregate RatingModerate Buy 2.80Holdings in CNCR have an aggregate rating of Moderate Buy based on 676 analyst ratings issued in the past year covering 75 companies (99.3% of the portfolio).CNCR Aggregate Price Target$8.88High Prediction$8.88Average Prediction$8.88Low Prediction$8.88Holdings in CNCR have an aggregate price target of $8.88 and a range of $8.88 to $8.88 covering 75 companies (99.3% of the portfolio).CNCR Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy33 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold13 Hold rating(s)Reduce3 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Range Cancer Therapeutics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 75 CNCR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.62%RXRXRecursion Pharmaceuticals$4.81-9.1%2.094 of 5 stars2.40$8.25 71.5%5Gap Down3.38%PGENPrecigen$1.34-9.5%3.0602 of 5 stars3.00$7.00 422.4%4Gap Down2.70%SWTXSpringWorks Therapeutics$43.07-7.4%1.9347 of 5 stars3.00$73.20 70.0%5Positive NewsGap Down2.70%CMPXCompass Therapeutics$1.61-5.0%3.0235 of 5 stars3.11$11.63 624.3%9Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap UpHigh Trading Volume2.51%EXELExelixis$36.68-1.0%4.4891 of 5 stars2.50$37.59 2.5%20Positive NewsGap Down2.51%GNLXGenelux$2.50-1.6%1.3044 of 5 stars3.20$18.25 630.0%5Earnings ReportAnalyst Revision2.22%BMYBristol-Myers Squibb$57.71-3.2%3.79 of 5 stars2.33$57.86 0.3%18Short Interest ↑Analyst RevisionPositive News2.17%SDGRSchrödinger$18.87-5.1%2.5277 of 5 stars3.00$32.29 71.1%8Gap Down2.10%GLUEMonte Rosa Therapeutics$3.89-11.8%3.0054 of 5 stars2.75$15.50 298.5%4Short Interest ↓2.10%DNAGinkgo Bioworks$5.71-4.3%0.5678 of 5 stars1.60$4.58 -19.8%5Gap Down2.09%REPLReplimune Group$7.89-8.5%3.553 of 5 stars3.13$19.43 146.2%8Positive NewsGap Down1.95%BPMCBlueprint Medicines$87.11-3.2%2.7306 of 5 stars2.70$124.95 43.4%23News CoveragePositive NewsGap Down1.93%TSVT2seventy bio$4.97+0.2%3.1481 of 5 stars2.38$6.67 34.1%81.84%ZYMEZymeworks$11.75-1.4%2.6049 of 5 stars2.88$21.00 78.7%8Insider TradePositive NewsGap Down1.78%HCMHUTCHMED$15.25-4.1%1.7266 of 5 stars2.00$19.00 24.6%11.76%MRUSMerus$41.73-3.0%2.0641 of 5 stars3.13$85.31 104.4%16News CoverageGap Down1.75%ACLXArcellx$62.44-7.1%2.0184 of 5 stars3.14$110.67 77.2%14News CoveragePositive NewsGap Down1.74%ELVNEnliven Therapeutics$20.03+0.9%2.7264 of 5 stars3.20$38.75 93.5%5Gap Down1.69%IPHAInnate Pharma$1.92+7.3%2.7227 of 5 stars3.50$11.50 499.0%2Gap Up1.67%VORVor Biopharma$0.59-6.9%2.2848 of 5 stars3.00$8.86 1,401.2%7Gap Down1.65%RVMDRevolution Medicines$32.87-5.0%4.12 of 5 stars3.08$65.23 98.5%13Analyst ForecastNews CoveragePositive NewsGap Down1.64%IMCRImmunocore$29.04-1.3%1.8464 of 5 stars2.54$65.64 126.0%13Positive NewsGap Down1.54%IBRXImmunityBio$2.97-2.6%1.9303 of 5 stars3.00$12.19 310.4%5Gap Down1.52%INBXInhibrx$13.33-5.5%1.8898 of 5 stars2.001News CoveragePositive News1.51%MRKMerck & Co., Inc.$86.32-0.3%5 of 5 stars2.65$117.12 35.7%23Analyst RevisionGap Up1.51%BNTXBioNTech$92.01-1.4%2.734 of 5 stars2.89$143.44 55.9%18Analyst ForecastGap Down1.45%GMABGenmab A/S$19.24+2.2%3.8134 of 5 stars2.69$41.33 114.8%13Analyst Downgrade1.38%AURAAura Biosciences$5.71-3.9%2.0989 of 5 stars3.25$23.00 302.8%8Gap DownHigh Trading Volume1.36%LEGNLegend Biotech$32.88-1.1%2.5849 of 5 stars2.92$79.00 140.3%12Short Interest ↓News CoveragePositive News1.34%SNDXSyndax Pharmaceuticals$12.46-3.9%3.4653 of 5 stars2.90$36.20 190.5%10Analyst Upgrade1.33%KYMRKymera Therapeutics$23.69-10.1%1.2553 of 5 stars2.87$56.36 137.9%15News CoverageGap Down1.32%ALLOAllogene Therapeutics$1.38-4.2%2.3514 of 5 stars2.90$9.29 573.1%10Gap Down1.32%SMMTSummit Therapeutics$18.91-7.6%2.7277 of 5 stars3.00$35.44 87.4%10Gap Down1.31%NUVBNuvation Bio$1.65-8.1%1.6752 of 5 stars3.25$8.75 431.9%4Gap Down1.29%NUVLNuvalent$68.32-3.0%2.3287 of 5 stars2.91$113.44 66.0%11News CoveragePositive NewsGap Down1.24%ACRVAcrivon Therapeutics$1.64-5.7%2.2473 of 5 stars3.00$23.17 1,312.6%8Gap Down1.22%MGNXMacroGenics$1.15-5.7%3.8271 of 5 stars2.36$7.38 541.3%11Gap Down1.16%JANXJanux Therapeutics$26.99-4.5%2.1198 of 5 stars3.08$92.44 242.5%12Gap Down1.14%ITOSiTeos Therapeutics$5.70-1.2%2.0322 of 5 stars3.00$25.75 351.8%4Gap Down1.14%RAPTRAPT Therapeutics$1.11-4.3%3.3866 of 5 stars2.11$4.00 260.4%9Gap Down1.13%XNCRXencor$8.92-9.2%3.5922 of 5 stars3.13$34.38 285.4%8Gap Down1.12%DAWNDay One Biopharmaceuticals$7.71-3.3%2.9829 of 5 stars3.13$32.29 318.8%8Analyst ForecastGap Down1.10%KPTIKaryopharm Therapeutics$3.86-4.9%3.3304 of 5 stars3.00$57.50 1,389.6%4Gap DownHigh Trading Volume1.09%REGNRegeneron Pharmaceuticals$610.64-2.4%4.7615 of 5 stars2.76$966.88 58.3%25Short Interest ↑Analyst Revision1.07%TYRATyra Biosciences$8.30-4.0%1.9212 of 5 stars3.00$30.83 271.5%6Analyst RevisionGap Down1.05%IMRXImmuneering$1.51-3.2%3.3375 of 5 stars2.33$12.50 727.8%3Short Interest ↓Positive NewsGap Down1.04%RCUSArcus Biosciences$7.16-9.3%2.2128 of 5 stars3.00$30.25 322.6%10Gap DownHigh Trading Volume1.04%APLMApollomics$6.71-16.1%2.4459 of 5 stars3.00$200.00 2,880.6%1News CoverageGap Down1.00%NRIXNurix Therapeutics$10.51-7.6%1.8163 of 5 stars2.83$30.88 193.8%18Upcoming EarningsAnalyst ForecastNews Coverage0.98%ACETAdicet Bio$0.67-7.3%3.2252 of 5 stars2.60$7.50 1,017.7%5Gap Down0.98%CGEMCullinan Therapeutics$7.49-4.2%2.0605 of 5 stars3.00$32.86 338.7%8News CoveragePositive NewsGap Down0.96%ERASErasca$1.21-4.0%3.6526 of 5 stars3.00$4.83 299.4%60.95%IDYAIDEAYA Biosciences$15.57-4.8%3.2618 of 5 stars2.93$53.58 244.1%15News CoverageGap Down0.93%CRBUCaribou Biosciences$0.79-8.7%2.9528 of 5 stars3.00$10.33 1,216.3%5Short Interest ↓Gap Down0.90%FHTXFoghorn Therapeutics$3.15-7.9%1.9548 of 5 stars3.00$13.17 318.0%6Gap Down0.90%ZNTLZentalis Pharmaceuticals$1.29-5.2%1.6051 of 5 stars2.44$8.24 541.6%9Gap Down0.89%LYELLyell Immunopharma$0.47-8.8%3.6209 of 5 stars1.50$1.00 115.1%2Positive NewsGap Down0.88%AUTLAutolus Therapeutics$1.51-3.8%2.4876 of 5 stars3.00$9.32 517.2%6Analyst ForecastGap Down0.85%RLAYRelay Therapeutics$2.29-8.0%2.1412 of 5 stars2.90$19.80 764.6%10Gap Down0.73%BCYCBicycle Therapeutics$7.43-7.7%1.5593 of 5 stars2.75$29.14 292.2%8Gap Down0.70%GERNGeron$1.47-7.5%4.3056 of 5 stars2.82$5.75 291.2%11Gap Down0.69%IOVAIovance Biotherapeutics$3.25-8.2%4.1431 of 5 stars2.88$20.25 523.1%8Gap Down0.67%IMTXImmatics$3.84-7.9%1.682 of 5 stars3.20$16.67 334.0%5Analyst ForecastAnalyst RevisionNews Coverage0.67%YMABY-mAbs Therapeutics$4.66-2.9%3.25 of 5 stars2.91$18.30 292.7%11Positive NewsGap DownHigh Trading Volume0.64%KURAKura Oncology$6.17-5.4%4.0631 of 5 stars2.92$25.50 313.3%12Analyst UpgradeGap Down0.63%ARVNArvinas$6.90-3.9%3.4147 of 5 stars2.67$35.50 414.5%15Gap DownHigh Trading Volume0.62%RPTXRepare Therapeutics$1.05-1.9%2.8915 of 5 stars2.50$4.50 328.6%4Gap Down0.60%BMEABiomea Fusion$1.95-9.7%2.85 of 5 stars3.00$23.91 1,126.1%13Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionGap Down0.57%AGENAgenus$1.60-1.8%3.1011 of 5 stars2.17$8.75 446.9%6Gap Down0.54%PRLDPrelude Therapeutics$0.71-10.0%2.6808 of 5 stars2.33$4.00 464.9%3Gap Down0.45%FATEFate Therapeutics$0.68-11.7%3.4915 of 5 stars2.22$5.43 698.3%9Gap Down0.44%MRSNMersana Therapeutics$0.31-9.9%4.3524 of 5 stars3.00$4.00 1,206.8%5Short Interest ↓Gap Down0.41%STROSutro Biopharma$0.59-6.0%3.8468 of 5 stars2.22$6.63 1,018.1%9Gap Down0.38%TNGXTango Therapeutics$1.27-7.3%1.968 of 5 stars3.00$12.33 871.1%7Positive NewsGap Down0.15%IGMSIGM Biosciences$1.16-5.7%4.7285 of 5 stars1.90$5.50 374.1%10Gap Down This page (NASDAQ:CNCR) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
